There is no shortage of people in need of a kidney transplant but a considerable shortage in the number of organs available to these patients. Despite that health care professionals in nephrology are determined to provide their patients the highest quality of life possible in spite of these challenges.
Studies of cancer risks with diabetes have been comprised mostly of people with T2DM, leaving the links between cancer and T1DM relatively unknown.
Many factors and competing responsibilities dictate how many patients you can see in one day. What’s your ideal number?
Unlike typical Western patients, type 2 diabetes patients in Asia tend to have lower BMIs. Does this mean responses to GLP-1 RAs differ as well?
When diabetes first became a concern in the medical community the numbers were lower, but the consequences were much more severe. Today, many more people are diagnosed with types one and two diabetes but the treatment options are much safer and more effective.
Latent autoimmune diabetes can be a tough diagnosis to make. Our blogger shares some pointers on this little-understood subtype of diabetes.
DCAN remains overlooked as an important risk factor for cardiac morbidity and mortality in diabetes.
SGLT2 inhibitors are known to lower blood pressure, but how best to use these drugs with blood pressure lowering medications remains an open question.
The Endocrine Society released a new clinical practice guideline covering diagnosis and treatment of primary adrenal insufficiency in January 2016. The European Society of Endocrinology and the American Association for Clinical Chemistry co-sponsored this document.
Older patients with type 2 diabetes are a highly variable population with different requirements for diabetes management.
The past 30 years have witnessed major advances in PCI; fewer changes have occurred with CABG, though the death rate has decreased. Which is better?
What will the burden on the health system be if non-compliant patients are dismissed from practices and deprived of care?
The hormonal changes of adolescence can wreak havoc on glucose control, but what else can affect disease management in teens?
A nutritionist's odd diet may call into question much of what your patients are often told about the need to consume “healthy†foods to affect certain markers of health, such as body mass index and levels of “good†and “bad†cholesterol levels.
Ideally, patients diagnosed with type 2 diabetes, metabolic syndrome, or obesity would take steps to address lifestyle factors. Often, their treatment teams are disappointed when these patients fail either to improve their diets or make healthy changes.
Muslims engage in an obligatory, month-long, sunrise-to-sunset fast once a year during Ramadan. In 2005, the American Diabetes Association developed recommendations for managing diabetes during Ramadan. They updated the recommendations in 2010, and this document has become one of their more popular publications.
The rise of type 1 diabetes rates corresponds with the widespread practice of childhood vaccinations in developed countries – coincidence or not?
The US Food and Drug Administration recently approved the Fenix Continence Restoration System for the treatment of fecal incontinence for patients who have tried and failed other medical and surgical options.
People who take a common drug for type 2 diabetes may be at risk for serious drug interactions if they add the blood thinner warfarin to the mix.
Is coffee good for you and your patients? What if it’s decaffeinated or loaded with sugar or cream? A new study adds fuel to the on-going debate.
Researchers say that patients using YouTube videos to obtain advice about their peripheral nerve pain are being misguided about half of the time.
The verdict is in regarding SGLT2 inhibitor use and diabetic ketoacidosis. Expert panel conclusions are summarized.
Three SGLT2 inhibitors have similar drug costs per unit dose, but what are the drug costs based on treatment response?
Changes in gut bacterial growth rates may be linked to onset of diseases, such as type 2 diabetes or irritable bowel syndrome, for example, according to research published in the journal Science.
Researchers sift through risk factors and clinical trial findings to determine if the SGLT2 inhibitor increases bladder cancer risk.
